Latest Amines Stories
Part One: "Treating Pain in Today's World: Avoiding the New Pitfalls" LOS ANGELES, April 9, 2014 /PRNewswire/ -- The Cooperative
Among patients with advanced non-small cell lung cancer without a mutation of a certain gene (EGFR), conventional chemotherapy, compared with treatment using epidermal growth factor receptor tyrosine kinase inhibitors, was associated with improvement in survival without progression of the cancer, but not with overall survival.
PORTLAND, Ore., April 9, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,
Mount Sinai Team Cautiously Optimistic That Door Could Swing Open to A New Antidepressant Drug Class New York, NY (PRWEB) April 08, 2014 A research team
Some scientists believe that this case of finding high levels of glyphosate in breast milk could be a re-run of the polychlorinated biphenyls (PCBs) scandal of the 1970s (1), which ended in the
BOSTON, April 7, 2014 /PRNewswire/ -- Ketanetics, LLC, a Massachusetts-based company founded by physicians, is expanding the Ketamine infusion centers it operates beyond Massachusetts and New
-- Clinically meaningful improvement in quality of life with single injection of resiniferatoxin SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics,
The street drug ketamine is now being looked at for its therapeutic value as a new study from UK researchers at Oxford University has found that relatively small doses of the drug are effective in treating depression.
Product has fast track designation by FDA RALEIGH, N.C., April 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
MONMOUTH JUNCTION, N.J., April 1, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.